CRMD
CorMedix Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.43
−0.47%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 17.33x
- P/E 2027E
- 140.94x
- P/E 2028E
- 19.11x
- P/S forward
- 2.63x
Trailing multiples
Trailing twelve months
- P/E TTM
- 3.50x
- PEG TTM
- —
- Price / book
- 1.43x
- Price / sales
- 1.42x
- Price / cash flow
- 2.59x
Enterprise value
- Enterprise value
- $545.5M
- EV / sales
- 1.18x
- EV / EBITDA
- 2.19x
- EV / EBIT
- 2.51x
- Market cap
- $657.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026